Etiologic characteristics revealed by mNGS-mediated ultra-early and early microbiological identification in airway secretions from lung transplant recipients
X Zhang, X Tang, X Yi, Y Lei, S Lu, T Li, R Yue… - Frontiers in …, 2023 - frontiersin.org
Background Post-operative etiological studies are critical for infection prevention in lung
transplant recipients within the first year. In this study, mNGS combined with microbial …
transplant recipients within the first year. In this study, mNGS combined with microbial …
Assessment of QuantiFERON®-CMV and Immuknow® assays in CMV-seropositive lung transplant recipients to stratify risk of CMV infection
V Monforte, H Sintes, P Ussetti… - Archivos de …, 2022 - pubmed.ncbi.nlm.nih.gov
Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung
Transplant Recipients to Stratify Risk of CMV Infection Assessment of Quantiferon®-CMV and …
Transplant Recipients to Stratify Risk of CMV Infection Assessment of Quantiferon®-CMV and …
[HTML][HTML] Policy List Edit Policy {{navigationConstituentPage. title||(navigationSitePage. urlName=='medicalpolicyhb'?'Healthy Blue Medical Policies':'Medical Policies')} …
HG Hormone-CAM - southcarolinablues.com
Recombinant human growth hormone (GH) is approved by the US Food and Drug
Administration (FDA) for various indications and is also proposed for various off-label …
Administration (FDA) for various indications and is also proposed for various off-label …